Parikh Shamik J 4

What Happened Shamik J. Parikh, Chief Medical Officer of Humacyte, reported the sale of 45,887 shares of Humacyte common stock on May 18, 2026. The shares were sold at $0.90 per share for total proceeds of roughly $41,147. This was a sale (a routine sell-to-cover tied to equity vesting), not a purchase.

Key Details

• Transaction date: 2026-05-18; Filing date: 2026-05-20 (filed timely).
• Transaction type/code: Sale (S) — open market/private sale recorded as a sell-to-cover.
• Price and amount: 45,887 shares at $0.90/share; proceeds ≈ $41,147.
• Shares owned after transaction: Not specified in the filing.
• Footnote: The sale was an automated "sell-to-cover" to satisfy statutory tax withholding on vested restricted stock units. It was mandated by the issuer’s practice and entered pursuant to a plan intended to meet the affirmative defense conditions of Rule 10b5-1(c); it therefore does not represent a discretionary sale by the reporting person.

Context Sell-to-cover transactions are common when restricted stock units vest and generally reflect tax-withholding mechanics rather than an executive’s decision to liquidate holdings for investment reasons. This filing is informational and does not, by itself, indicate insider sentiment about company prospects.